DK1874761T3 - 4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer - Google Patents

4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer

Info

Publication number
DK1874761T3
DK1874761T3 DK06755440.2T DK06755440T DK1874761T3 DK 1874761 T3 DK1874761 T3 DK 1874761T3 DK 06755440 T DK06755440 T DK 06755440T DK 1874761 T3 DK1874761 T3 DK 1874761T3
Authority
DK
Denmark
Prior art keywords
nicotine
triazine
alpha
derivatives
preparation
Prior art date
Application number
DK06755440.2T
Other languages
English (en)
Inventor
Yannick Benedetti
Andrees Bohme
Arielle Genevois-Borella
Gaetan Touyer
Jidong Zhang
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1874761T3 publication Critical patent/DK1874761T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK06755440.2T 2005-04-22 2006-04-21 4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer DK1874761T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504042A FR2884822B1 (fr) 2005-04-22 2005-04-22 Derives de triazines, leur preparation et leur application en therapeutique
PCT/FR2006/000887 WO2006111662A2 (fr) 2005-04-22 2006-04-21 Derives de 4h-1 , 2 , 4-triazin-5-0nes , leur preparation et leur utilisation comme des recepteurs a l'acetylcholine de type nicotiniques alpha7

Publications (1)

Publication Number Publication Date
DK1874761T3 true DK1874761T3 (da) 2010-12-13

Family

ID=35219499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06755440.2T DK1874761T3 (da) 2005-04-22 2006-04-21 4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer

Country Status (17)

Country Link
US (1) US7517881B2 (da)
EP (1) EP1874761B1 (da)
JP (1) JP4966295B2 (da)
AR (1) AR054033A1 (da)
AT (1) ATE478068T1 (da)
CY (1) CY1111288T1 (da)
DE (1) DE602006016258D1 (da)
DK (1) DK1874761T3 (da)
ES (1) ES2350950T3 (da)
FR (1) FR2884822B1 (da)
HR (1) HRP20100604T1 (da)
PL (1) PL1874761T3 (da)
PT (1) PT1874761E (da)
RS (1) RS51557B (da)
SI (1) SI1874761T1 (da)
TW (1) TW200708506A (da)
WO (1) WO2006111662A2 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
AR049401A1 (es) 2004-06-18 2006-07-26 Novartis Ag Aza-biciclononanos
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
TWI558398B (zh) 2009-09-22 2016-11-21 諾華公司 菸鹼乙醯膽鹼受體α７活化劑之用途
EP3455223B1 (en) * 2016-05-12 2023-11-08 Buck Institute for Research on Aging Compounds to promote normal processing of app

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4774604B2 (ja) * 2000-02-14 2011-09-14 和光純薬工業株式会社 第４級アンモニウム塩の製造方法
JP4616971B2 (ja) * 2000-07-18 2011-01-19 田辺三菱製薬株式会社 １−アザビシクロアルカン化合物およびその医薬用途
IL160884A0 (en) * 2001-10-02 2004-08-31 Upjohn Co Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
SE0301320D0 (sv) * 2003-05-06 2003-05-06 Astrazeneca Ab Positive modulators of nicotinic acetylcholine receptors

Also Published As

Publication number Publication date
EP1874761A2 (fr) 2008-01-09
FR2884822B1 (fr) 2007-06-29
EP1874761B1 (fr) 2010-08-18
ES2350950T3 (es) 2011-01-28
JP4966295B2 (ja) 2012-07-04
JP2008536902A (ja) 2008-09-11
HRP20100604T1 (hr) 2010-12-31
FR2884822A1 (fr) 2006-10-27
PT1874761E (pt) 2010-11-18
ATE478068T1 (de) 2010-09-15
WO2006111662A3 (fr) 2006-11-30
DE602006016258D1 (de) 2010-09-30
WO2006111662A2 (fr) 2006-10-26
CY1111288T1 (el) 2015-08-05
US7517881B2 (en) 2009-04-14
TW200708506A (en) 2007-03-01
US20080096891A1 (en) 2008-04-24
AR054033A1 (es) 2007-05-30
RS51557B (en) 2011-06-30
SI1874761T1 (sl) 2010-12-31
PL1874761T3 (pl) 2011-02-28

Similar Documents

Publication Publication Date Title
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
ZA200709856B (en) Fluorene derivatives,compositions containing said derivatives and the use thereof
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
DK1824856T3 (da) 2,4 (4,6)-pyrimidinderivater
IL191655A0 (en) Novel compounds, their preparation and use
DK1833791T3 (da) 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister
NO20054015D0 (no) Hurtige absorpsjons selektive 5-HT agonist formuleringer.
IL187392A0 (en) Thiazole derivatives, their preparation and use
HK1103073A1 (en) Substituted diaza-spiro-[5.5-undecane derivatives and their use as neurokinin antagonists
DK1874761T3 (da) 4h-1,2,4-triazin-5-on-derivater, fremstilling heraf og anvendelse heraf som alpha-7-nikotin-acetylcholin-receptorer
IL178461A0 (en) Substituted 4-alkyl -and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
DE602004021572D1 (de) SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
ATE518848T1 (de) 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazinderivate
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
DK1928464T3 (da) Ny parenteral carbamazepin-formulering
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
ITMI20051155A1 (it) Nuovi composti fluorurati, loro sintesi e uso.
FI20055133A (fi) Iskulaite
IL190334A0 (en) Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
DE602006018617D1 (de) Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten